Government fund of funds
Development institute of the Russian Federation

Photo reports

SPIEF-2019. Expert session "Innovative development of pharmaceutical and biotechnological industry in Russia: conditions for success“

The treatment of oncological and orphan diseases as well as the implementation of machine learning and AI technologies in medicine is impossible without innovations from medicobiologic companies. The participants of the session “Innovative development of the pharmaceutical and biotechnological industry in Russia: conditions for success“ discussed the main challenges of the industry and the main tools of its support at the SPIEF. Alexey Basov, Deputy General Director, Investment Director of RVC, took part in the session.

Search by name:

Search by date:

Select date in calendar
Select date in calendar

Venue: